Drug: emend Quarter: 2016Q3
Total Records: 233 Number of Pages: 12
DRUGNAME | PT | EventCount |
---|---|---|
EMEND | Pulmonary toxicity | 1 |
EMEND | Rash erythematous | 1 |
EMEND | Recurrent cancer | 1 |
EMEND | Renal disorder | 1 |
EMEND | Respiration abnormal | 1 |
EMEND | Seizure | 1 |
EMEND | Skin warm | 1 |
EMEND | Stevens-Johnson syndrome | 1 |
EMEND | Stridor | 1 |
EMEND | Terminal state | 1 |
EMEND | Toxicity to various agents | 1 |
EMEND | Vein disorder | 1 |
EMEND | Wheezing | 1 |
EMEND (FOSAPREPITANT DIMEGLUMINE) | Abdominal pain | 1 |
EMEND (FOSAPREPITANT DIMEGLUMINE) | Cerebrovascular accident | 1 |
EMEND (FOSAPREPITANT DIMEGLUMINE) | Colon cancer | 1 |
EMEND (FOSAPREPITANT DIMEGLUMINE) | Depressed level of consciousness | 1 |
EMEND (FOSAPREPITANT DIMEGLUMINE) | Diarrhoea | 1 |
EMEND (FOSAPREPITANT DIMEGLUMINE) | Dizziness | 1 |
EMEND (FOSAPREPITANT DIMEGLUMINE) | Drug ineffective | 1 |
Total Records: 233 Number of Pages: 12